0
0

Greater Access to Affordable Pharmaceuticals Act of 2001

1/16/2023, 3:33 PM

Congressional Summary of HR 1862

Greater Access to Affordable Pharmaceuticals Act of 2001 - Amends the Federal Food, Drug, and Cosmetic Act to provide for an accelerated date of approval for a generic drug application.

Allows a drug to be considered a bioequivalent to a listed drug if the effects of such drug and the listed drug do not show a significant difference based on certain tests or studies.

Sets forth requirements concerning the filing of a citizen petition review.

Revises provisions concerning: (1) abbreviated new drug applications and new drug applications with respect to the time required for approval and the certification that a patent is invalid or will not be infringed; and (2) filing an application.

Requires a report concerning the extent to which this Act has: (1) has enabled products to come to market in a fair and expeditious manner, consistent with the rights of patent owners under intellectual property law; and (2) has promoted lower prices of drugs and greater access to drugs through price competition..

Read the Full Bill

Current Status of Bill HR 1862

Bill HR 1862 is currently in the status of Bill Introduced since May 16, 2001. Bill HR 1862 was introduced during Congress 107 and was introduced to the House on May 16, 2001.  Bill HR 1862's most recent activity was Sponsor introductory remarks on measure. (CR H2110) as of May 7, 2002

Bipartisan Support of Bill HR 1862

Total Number of Sponsors
1
Democrat Sponsors
1
Republican Sponsors
0
Unaffiliated Sponsors
0
Total Number of Cosponsors
62
Democrat Cosponsors
54
Republican Cosponsors
7
Unaffiliated Cosponsors
1

Policy Area and Potential Impact of Bill HR 1862

Primary Policy Focus

Health

Potential Impact Areas

- Administrative procedure
- Administrative remedies
- Civil actions and liability
- Commerce
- Competition
- Congress
- Congressional reporting requirements
- Consent decrees
- Department of Health and Human Services
- Drug approvals
- Drug industry
- Generic drugs
- Government Operations and Politics
- Government paperwork
- Governmental investigations
- Intellectual property
- Judicial opinions
- Law
- Patents
- Pharmaceutical research
- Prescription pricing
- Restrictive trade practices
- Right of petition
- Science, Technology, Communications

Alternate Title(s) of Bill HR 1862

Greater Access to Affordable Pharmaceuticals Act of 2001
To amend the Federal Food, Drug, and Cosmetic Act to provide greater access to affordable pharmaceuticals.
Greater Access to Affordable Pharmaceuticals Act of 2001

Comments

Latest Bills

To amend the FISA Amendments Act of 2008 to extend the authorities of title VII of the Foreign Intelligence Surveillance Act of 1978 through April 30, 2026, and for other purposes.
Bill HR 8322April 19, 2026
Space Exploration Research Act
Bill S 2351April 18, 2026
RED Tape Act
Bill HR 6398April 18, 2026
FENCES Act
Bill HR 6409April 18, 2026
A bill to extend section 702 of the Foreign Intelligence Surveillance Act of 1978 for 3 years.
Bill S 4344April 18, 2026
A bill to amend title 5, United States Code, to provide that a Member of Congress convicted of certain felony offenses relating to sexual abuse shall not be eligible for retirement benefits based on that individual's Member service, and for other purposes.
Bill S 4343April 18, 2026
SAFER Transport Act
Bill HR 8267April 18, 2026
National Wildlife Refuge System Invasive Species Strike Team Act of 2025
Bill HR 4219April 18, 2026
To amend the Marine Mammal Protection Act of 1972 to allow importation of polar bear trophies taken in sport hunts in Canada before the date the polar bear was determined to be a threatened species under the Endangered Species Act of 1973.
Bill HR 6251April 18, 2026
Western South Dakota Water Supply Project Feasibility Study Act
Bill HR 7288April 18, 2026
Greater Access to Affordable Pharmaceuticals Act of 2002
Bill S 812January 16, 2023
Providing for consideration of the bill (H.R. 1862) to amend the Federal Food, Drug, and Cosmetic Act to provide greater access to affordable pharmaceuticals.
Bill HRES 517January 16, 2023